Veracyte Inc. | Key People and Executives
Bonnie H. Anderson
Chairman & Chief Executive Officer
Kevin K. Gordon
Independent Director
John L. Bishop
Lead Independent Director
Tina Susan Nova
Independent Director
Robert S. Epstein
Independent Director
Jesse I. Treu
Independent Director
Karin Eastham
Independent Director
Evan Jones
Independent Director
Fred E. Cohen
Independent Director
Bonnie H. Anderson
Chairman & Chief Executive Officer
Christopher M. Hall
President & Chief Operating Officer
Keith Kennedy
Chief Financial Officer & Secretary
Giulia C. Kennedy
Chief Scientific & Medical Officer
Ashish Kheterpal
Chief Information Officer
John W. Hanna
Chief Commercial Officer
Jessica Meng
Vice President-Marketing
Angeline C. McCabe
VP-Investor Relations & Corporate Communications
Tracy Morris
Head-Media Relations
Julie A. Brooks
Executive Vice President & General Counsel
Kevin K. Gordon
Independent Director
John L. Bishop
Lead Independent Director
Tina Susan Nova
Independent Director
Robert S. Epstein
Independent Director
Jesse I. Treu
Independent Director
Karin Eastham
Independent Director
Evan Jones
Independent Director
Fred E. Cohen
Independent Director
| Address |
6000 Shoreline Court
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.veracyte.com |
| Updated |
07/08/2019 |
| Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. |
